文献速递重症综合管理与镇静镇痛

1997至2013年英格兰、威尔士和北爱尔兰癌症患者非计划ICU入住的特征与结局及全国趋势

Characteristics and Outcome of Cancer Patients Admitted to the ICU in England, Wales, and Northern Ireland and National Trends Between 1997 and 2013.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论1997至2013年癌症患者非计划ICU入住后ICU及住院死亡率与住院时间显著下降,2009至2013年实体瘤住院死亡率26.4%、血液肿瘤53.6%。

该研究为回顾性分析,基于重症监护国家审计与研究中心病例组合计划数据库,纳入英格兰、威尔士和北爱尔兰ICU中1997至2013年非计划入院的99,590例实体瘤患者和13,538例血液肿瘤患者,并对2009至2013年入院的39,734例实体瘤和6,652例血液肿瘤患者深入分析。实体瘤患者住院死亡率为26.4%,血液肿瘤患者为53.6%。实体瘤住院死亡的独立危险因素包括转移性疾病(OR 1.99)、ICU前心肺复苏(OR 1.63)、ICNARC生理评分(OR 1.14)、因胃肠道(OR 1.12)、呼吸(OR 1.48)或神经系统(OR 1.65)原因入院及既往ICU入住(OR 1.18);血液肿瘤的独立危险因素包括年龄(OR 1.02)、ICU前心肺复苏(OR 1.90)、ICNARC生理评分(OR 1.12)、因血液(OR 1.48)或呼吸(OR 1.56)原因入院、骨髓移植(OR 1.53)、既往ICU入住(OR 1.43)及入ICU 24小时内机械通气(OR 1.33)。趋势分析显示1997至2013年ICU和住院死亡率及住院时间显著下降,而病情严重程度变化不大。

要点

  • 2009至2013年实体瘤非计划ICU入住患者住院死亡率为26.4%,血液肿瘤患者为53.6%。
  • 实体瘤住院死亡的独立危险因素包括转移性疾病(OR 1.99)和ICU前心肺复苏(OR 1.63)。
  • 血液肿瘤住院死亡的独立危险因素包括ICU前心肺复苏(OR 1.90)和入ICU 24小时内机械通气(OR 1.33)。
  • 1997至2013年癌症患者非计划ICU入住后ICU及住院死亡率和住院时间显著下降,病情严重程度变化不大。

适用人群与场景

  • 1997至2013年英格兰、威尔士和北爱尔兰ICU中非计划入院的癌症患者,包括99,590例实体瘤和13,538例血液肿瘤患者。
  • 深入分析2009至2013年入院的39,734例实体瘤和6,652例血液肿瘤患者。

研究设计与关键结果

  • 研究类型为回顾性分析,数据来自重症监护国家审计与研究中心病例组合计划数据库,覆盖英格兰、威尔士和北爱尔兰的ICU。
  • 2009至2013年实体瘤患者住院死亡率为26.4%;独立危险因素包括转移性疾病(OR 1.99)、ICU前心肺复苏(OR 1.63)、ICNARC生理评分(OR 1.14)、因胃肠道(OR 1.12)、呼吸(OR 1.48)或神经系统(OR 1.65)原因入院及既往ICU入住(OR 1.18)。
  • 2009至2013年血液肿瘤患者住院死亡率为53.6%;独立危险因素包括年龄(OR 1.02)、ICU前心肺复苏(OR 1.90)、ICNARC生理评分(OR 1.12)、因血液(OR 1.48)或呼吸(OR 1.56)原因入院、骨髓移植(OR 1.53)、既往ICU入住(OR 1.43)及入ICU 24小时内机械通气(OR 1.33)。
  • 趋势分析显示1997至2013年ICU和住院死亡率及住院时间显著下降,而病情严重程度变化不大。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To describe trends in outcomes of cancer patients with an unplanned admission to the ICU between 1997 and 2013 and to identify risk factors for mortality of those admitted between 2009 and 2013.

DESIGN: Retrospective analysis.

SETTING: Intensive Care National Audit & Research Centre Case Mix Programme Database including data of ICUs in England, Wales, and Northern Ireland.

PATIENTS: Patients (99,590) with a solid tumor and 13,538 patients with a hematological malignancy with an unplanned ICU admission between 1997 and 2013; 39,734 solid tumor patients and 6,652 patients with a hematological malignancy who were admitted between 2009 and 2013 were analyzed in depth.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: In solid tumor patients admitted between 2009 and 2013, hospital mortality was 26.4%. Independent risk factors for hospital mortality were metastatic disease (odds ratio, 1.99), cardiopulmonary resuscitation before ICU admission (odds ratio, 1.63), Intensive Care National Audit & Research Centre Physiology score (odds ratio, 1.14), admission for gastrointestinal (odds ratio, 1.12), respiratory (odds ratio, 1.48) or neurological (odds ratio, 1.65) reasons, and previous ICU admission (odds ratio, 1.18). In patients with a hematological malignancy admitted between 2009 and 2013, hospital mortality was 53.6%. Independent risk factors for hospital mortality were age (odds ratio, 1.02), cardiopulmonary resuscitation before ICU admission (odds ratio, 1.90), Intensive Care National Audit & Research Centre Physiology Score (odds ratio, 1.12), admission for hematological (odds ratio, 1.48) or respiratory (odds ratio, 1.56) reasons, bone marrow transplant (odds ratio, 1.53), previous ICU admission (odds ratio, 1.43), and mechanical ventilation within 24 hours of admission (odds ratio, 1.33). Trend analysis showed a significant decrease in ICU and hospital mortality and length of stay between 1997 and 2013 despite little change in severity of illness during this time.

CONCLUSIONS: Between 1997 and 2013, the outcome of cancer patients with an unplanned admission to ICU improved significantly. Among those admitted between 2009 and 2013, independent risk factors for hospital mortality were age, severity of illness, previous cardiopulmonary resuscitation, previous ICU admission, metastatic disease, and admission for respiratory reasons.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Ostermann M, Ferrando-Vivas P, Gore C, et al. Characteristics and Outcome of Cancer Patients Admitted to the ICU in England, Wales, and Northern Ireland and National Trends Between 1997 and 2013. Crit Care Med. 2017. PMID: 28682838. doi:10.1097/CCM.0000000000002589

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。